These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8176479

  • 1. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.
    Shih LB, Thorpe SR, Griffiths GL, Diril H, Ong GL, Hansen HJ, Goldenberg DM, Mattes MJ.
    J Nucl Med; 1994 May; 35(5):899-908. PubMed ID: 8176479
    [Abstract] [Full Text] [Related]

  • 2. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R, Goldenberg DM, Thorpe SR, Basu A, Mattes MJ.
    Cancer Res; 1995 Jul 15; 55(14):3132-9. PubMed ID: 7606734
    [Abstract] [Full Text] [Related]

  • 3. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
    Press OW, Shan D, Howell-Clark J, Eary J, Appelbaum FR, Matthews D, King DJ, Haines AM, Hamann P, Hinman L, Shochat D, Bernstein ID.
    Cancer Res; 1996 May 01; 56(9):2123-9. PubMed ID: 8616860
    [Abstract] [Full Text] [Related]

  • 4. Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells.
    Mattes MJ, Griffiths GL, Diril H, Goldenberg DM, Ong GL, Shih LB.
    Cancer; 1994 Feb 01; 73(3 Suppl):787-93. PubMed ID: 8306261
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z, Garmestani K, Wong KJ, Park LS, Dadachova E, Yordanov A, Waldmann TA, Eckelman WC, Paik CH, Carrasquillo JA.
    J Nucl Med; 2001 Oct 01; 42(10):1538-44. PubMed ID: 11585870
    [Abstract] [Full Text] [Related]

  • 7. Improved iodine radiolabels for monoclonal antibody therapy.
    Stein R, Govindan SV, Mattes MJ, Chen S, Reed L, Newsome G, McBride BJ, Griffiths GL, Hansen HJ, Goldenberg DM.
    Cancer Res; 2003 Jan 01; 63(1):111-8. PubMed ID: 12517786
    [Abstract] [Full Text] [Related]

  • 8. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 01; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 9. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [Abstract] [Full Text] [Related]

  • 10. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A.
    J Nucl Med; 2001 Jan 01; 42(1):146-53. PubMed ID: 11197965
    [Abstract] [Full Text] [Related]

  • 11. Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells.
    Geissler F, Anderson SK, Venkatesan P, Press O.
    Cancer Res; 1992 May 15; 52(10):2907-15. PubMed ID: 1581908
    [Abstract] [Full Text] [Related]

  • 12. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
    Michel RB, Brechbiel MW, Mattes MJ.
    J Nucl Med; 2003 Apr 15; 44(4):632-40. PubMed ID: 12679410
    [Abstract] [Full Text] [Related]

  • 13. The fate of antibodies bound to the surface of tumor cells in vitro.
    Kyriakos RJ, Shih LB, Ong GL, Patel K, Goldenberg DM, Mattes MJ.
    Cancer Res; 1992 Feb 15; 52(4):835-42. PubMed ID: 1737345
    [Abstract] [Full Text] [Related]

  • 14. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22.
    Sharkey RM, Behr TM, Mattes MJ, Stein R, Griffiths GL, Shih LB, Hansen HJ, Blumenthal RD, Dunn RM, Juweid ME, Goldenberg DM.
    Cancer Immunol Immunother; 1997 May 15; 44(3):179-88. PubMed ID: 9191878
    [Abstract] [Full Text] [Related]

  • 15. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG, Oosterwijk E, Soede AC, Broekema M, Frielink C, McBride WJ, Goldenberg DM, Corstens FH, Boerman OC.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [Abstract] [Full Text] [Related]

  • 16. Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
    van Schaijk FG, Broekema M, Oosterwijk E, van Eerd JE, McBride BJ, Goldenberg DM, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Jun 01; 46(6):1016-22. PubMed ID: 15937314
    [Abstract] [Full Text] [Related]

  • 17. A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response.
    Jacobs AJ, Fer M, Su FM, Breitz H, Thompson J, Goodgold H, Cain J, Heaps J, Weiden P.
    Obstet Gynecol; 1993 Oct 01; 82(4 Pt 1):586-93. PubMed ID: 8377986
    [Abstract] [Full Text] [Related]

  • 18. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons.
    Michel RB, Castillo ME, Andrews PM, Mattes MJ.
    Clin Cancer Res; 2004 Sep 01; 10(17):5957-66. PubMed ID: 15355929
    [Abstract] [Full Text] [Related]

  • 19. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 01; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 20. Antibody localization to B-cell lymphoma xenografts in immunodeficient mice: importance of using residualizing radiolabels.
    Michel RB, Ochakovskaya R, Mattes MJ.
    Clin Cancer Res; 2002 Aug 01; 8(8):2632-9. PubMed ID: 12171895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.